HYSERPIN Drug Patent Profile
When do Hyserpin patents expire, and when can generic versions of Hyserpin launch?
Hyserpin is a drug marketed by Phys Prods Va and is included in one NDA.
The generic ingredient in HYSERPIN is rauwolfia serpentina root. There is one drug master file entry for this compound. Additional details are available on the rauwolfia serpentina root profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for HYSERPIN?
- What are the global sales for HYSERPIN?
- What is Average Wholesale Price for HYSERPIN?
Summary for HYSERPIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | HYSERPIN at DailyMed |
US Patents and Regulatory Information for HYSERPIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Phys Prods Va | HYSERPIN | rauwolfia serpentina root | TABLET;ORAL | 010581-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
